Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals, Upcoming Webinar Hosted by Xtalks


Topics in this webinar will include:

  • Background on nitrosamines, including factors that increase the risk of contamination in pharmaceuticals
  • Recent scientific developments that have enhanced the requirements for risk assessment, testing and mitigation
  • Regulatory guidance on assessing the risk of — and identifying the root cause for — potential nitrosamine impurities
  • Reporting and notification requirements for nitrosamines in pharmaceuticals
  • Recent Food and Drug Administration (FDA) guidance on nitrosamine drug substance-related impurities (NDSRIs) and implementation requirements

Join this webinar to gain insights into nitrosamine contamination in drug manufacturing and the current scientific and regulatory landscape.

Join experts from Premier Consulting, Dr. Olu Aloba, Vice President, CMC Services; and Dr. Marianthi Karakatsani, Director, CMC Development Strategy, for the live webinar on Thursday, October 19, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit 2023 RAPS Article of The Year: Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Leave a Reply